CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of CKD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
6125 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C01701 | BRD-K10974103 | diloxanide | protein synthesis inhibitor | Details | ||
C01702 | BRD-K24023109 | diltiazem | CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5 | calcium channel blocker | Details | |
C01703 | BRD-K23541596 | dimaprit | HRH2|HRH3|HRH4 | histamine receptor agonist | Details | |
C01704 | BRD-K29812331 | dimemorfan | SIGMAR1 | sigma receptor agonist | Details | |
C01705 | BRD-M98649031 | dimenhydrinate | HRH1 | histamine receptor antagonist | Details | |
C01706 | BRD-A56152450 | dimercaprol | chelating agent | Details | ||
C01707 | BRD-K88701661 | dimercaptosuccinic-acid | DNMT1 | chelating agent | Details | |
C01708 | BRD-K30126819 | dimesna | tubulin polymerization inhibitor | Details | ||
C01709 | BRD-K43687498 | dimethadione | oxazolidine antiepileptic | Details | ||
C01710 | BRD-K26674746 | dimethicone | Details | |||
C01711 | BRD-K83192048 | dimethindene-(S)-(+) | HRH1 | acetylcholine receptor antagonist | Details | |
C01712 | BRD-K73391359 | dimethisoquin | local anesthetic | Details | ||
C01713 | BRD-K31111078 | dimethyl-fumarate | KEAP1 | nuclear factor erythroid derived; like (NRF2) activator | Details | |
C01714 | BRD-A17224697 | dimethyl-isosorbide | cosmetic moisturizer | Details | ||
C01715 | BRD-A54141700 | dimetindene | CHRM2|HRH1 | histamine receptor antagonist; cholinergic receptor antagonist | Details | |
C01716 | BRD-K72728560 | dimetridazole | bacterial DNA inhibitor | Details | ||
C01717 | BRD-K92848252 | diminazene-aceturate | AOC1|PRDX5|PRSS1 | angiotensin converting enzyme activator | Details | |
C01718 | BRD-K60567437 | dimpylate | ACHE | acetylcholinesterase inhibitor | Details | |
C01719 | BRD-K13662825 | dinaciclib | CDK1|CDK2|CDK5|CDK9 | CDK inhibitor | Details | |
C01720 | BRD-K93240442 | dinitolmide | Details | |||
C01721 | BRD-K81672972 | dinoprost | PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|PTGIR|TBXA2R | prostacyclin analog | Details | |
C01722 | BRD-K26521938 | dinoprostone | CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R | prostanoid receptor agonist | Details | |
C01723 | BRD-K37723606 | dioscin | CXCR3 | apoptosis stimulant | Details | |
C01724 | BRD-K28690501 | diosgenin | steroid | Details | ||
C01725 | BRD-K26862302 | diosmetin | CYP1B1 | aryl hydrocarbon receptor agonist | Details | |
C01726 | BRD-K94436377 | diosmin | AHR | aryl hydrocarbon receptor agonist; capillary stabilizing agent | Details | |
C01727 | BRD-K22193694 | dioxybenzone | topical sunscreen agent | Details | ||
C01728 | BRD-K11595419 | dipeptamin | Details | |||
C01729 | BRD-A30693873 | diperodon | local anesthetic | Details | ||
C01730 | BRD-K93441486 | diphemanil | CHRM3 | acetylcholine receptor antagonist | Details | |
C01731 | BRD-K51730347 | diphencyprone | immunostimulant | Details | ||
C01732 | BRD-K47278471 | diphenhydramine | HRH1 | histamine receptor antagonist | Details | |
C01733 | BRD-K01663662 | diphenidol | CHRM1|CHRM2|CHRM3|CHRM4 | acetylcholine receptor agonist | Details | |
C01734 | BRD-K65814004 | diphenyleneiodonium | NOS2|NOS3 | nitric oxide synthase inhibitor | Details | |
C01735 | BRD-K12362304 | diphenylguanidine | Details | |||
C01736 | BRD-K22936972 | diphenylpyraline | HRH1|SLC6A3 | dopamine uptake inhibitor | Details | |
C01737 | BRD-A47494775 | dipivefrine | ACHE|ADRA1A|ADRA2A|ADRB2|BCHE | adrenergic receptor agonist | Details | |
C01738 | BRD-K64838454 | dipraglurant | GRM5 | glutamate receptor negative allosteric modulator | Details | |
C01739 | BRD-K75385383 | DIPT | HTR1A|HTR2A|HTR2C | dopamine reuptake inhibitor; serotonin reuptake inhibitor | Details | |
C01740 | BRD-K86301799 | dipyridamole | ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1 | phosphodiesterase inhibitor | Details | |
C01741 | BRD-K47608922 | dipyrocetyl | chelating agent | Details | ||
C01742 | BRD-K52756523 | dirithromycin | bacterial 50S ribosomal subunit inhibitor | Details | ||
C01743 | BRD-K87386013 | diroximel-fumarate | anti-inflammatory agent | Details | ||
C01744 | BRD-K66672047 | disodium sebacate | HBA1|HBB | Details | ||
C01745 | BRD-A29734509 | disopyramide | CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A | sodium channel blocker | Details | |
C01746 | BRD-K32744045 | disulfiram | ALDH2|DBH | aldehyde dehydrogenase inhibitor; DNA methyltransferase inhibitor; TRPV agonist | Details | |
C01747 | BRD-K51807679 | dithranol | DNA synthesis inhibitor | Details | ||
C01748 | BRD-K40654626 | ditiocarb-sodium-trihydrate | CA1|CA2|CA4 | immunostimulant | Details | |
C01749 | BRD-K33459542 | ditolylguanidine | GRIN1|GRIN2A|GRIN2B|SIGMAR1 | sigma receptor agonist | Details | |
C01750 | BRD-K41260949 | divalproex-sodium | ALDH5A1 | benzodiazepine receptor agonist | Details | |
C01751 | BRD-K05919151 | dixanthogen | Details | |||
C01752 | BRD-K58930050 | dizocilpine-(+) | GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D | glutamate receptor antagonist | Details | |
C01753 | BRD-K23163214 | dizocilpine-(-) | glutamate receptor antagonist | Details | ||
C01754 | BRD-K26573499 | DMAB-anabaseine | CHRNA7 | adrenergic receptor agonist | Details | |
C01755 | BRD-K36775483 | DMeOB | GRM5 | Details | ||
C01756 | BRD-K39381259 | DMH1 | ACVR1 | ALK tyrosine kinase receptor inhibitor | Details | |
C01757 | BRD-K40575944 | DMH4 | KDR | VEGFR inhibitor | Details | |
C01758 | BRD-K03564313 | DMNB | DNA dependent protein kinase inhibitor | Details | ||
C01759 | BRD-K89274813 | DMP-543 | acetylcholine release enhancer | Details | ||
C01760 | BRD-K54936858 | DMP-777 | MPO | elastase inhibitor | Details | |
C01761 | BRD-A22971209 | DMPS | chelating agent | Details | ||
C01762 | BRD-M56212252 | DMSO | control vehicle | Details | ||
C01763 | BRD-K64400208 | DNQX | GRIA1|GRIA2|GRIK1|GRIN1|GRIN2A|GRIN2B | glutamate receptor antagonist | Details | |
C01764 | BRD-A78322124 | dobutamine | ADRB1|ADRB2 | adrenergic receptor agonist | Details | |
C01765 | BRD-K08290224 | docebenone | ALOX5 | lipoxygenase inhibitor | Details | |
C01766 | BRD-K30577245 | docetaxel | BCL2|MAP2|MAP4|MAPT|NR1I2|TUBB|TUBB1 | tubulin polymerization inhibitor | Details | |
C01767 | BRD-K39965020 | doconexent | FFAR1|PTGS1|PTGS2 | PPAR receptor agonist | Details | |
C01768 | BRD-K61937613 | doconexent-ethyl-ester | omega 3 fatty acid stimulant | Details | ||
C01769 | BRD-K50050533 | docosanol | TLR7 | lipase clearing factor inhibitor | Details | |
C01770 | BRD-A00092689 | docusate | laxative | Details | ||
C01771 | BRD-K05680146 | dodecyl-sulfate | LYZ | Details | ||
C01772 | BRD-A14941520 | dofequidar | ABCB1 | MRP inhibitor; P glycoprotein inhibitor | Details | |
C01773 | BRD-K86887724 | dofetilide | KCNH1|KCNH2|KCNJ12|KCNK2 | potassium channel blocker | Details | |
C01774 | BRD-K28029915 | dolasetron | HTR3A | serotonin receptor antagonist | Details | |
C01775 | BRD-K78567475 | dolastatin-10 | TUBB | tubulin polymerization inhibitor | Details | |
C01776 | BRD-K36386086 | dolutegravir | CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1 | HIV integrase inhibitor | Details | |
C01777 | BRD-K30431096 | domiphen | Details | |||
C01778 | BRD-K38305202 | domperidone | DRD2|DRD3 | dopamine receptor antagonist | Details | |
C01779 | BRD-A49160188 | donepezil | ACHE|HTR2A | acetylcholinesterase inhibitor | Details | |
C01780 | BRD-K31092604 | donitriptan | HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6 | serotonin receptor agonist | Details | |
C01781 | BRD-K43887077 | dopamine | DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4 | dopamine receptor agonist | Details | |
C01782 | BRD-K74065929 | doramapimod | MAPK11|MAPK12|MAPK13|MAPK14 | p38 MAPK inhibitor | Details | |
C01783 | BRD-A16350940 | doramectin | Details | |||
C01784 | BRD-K45319714 | doripenem | DPEP1 | bacterial cell wall synthesis inhibitor | Details | |
C01785 | BRD-K54233340 | dorsomorphin | ACVR1|BMPR1A|BMPR1B|EPHA2|FKBP1A|FLT1|FLT3|KDR|LCK|MKNK1|PRKAA1|RPS6KA1|SRC | AMPK inhibitor | Details | |
C01786 | BRD-K71075609 | dorzolamide | CA1|CA12|CA14|CA2|CA4|CA7 | carbonic anhydrase inhibitor | Details | |
C01787 | BRD-K54759182 | dosulepin | CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4 | norepinephrine reuptake inhibitor; serotonin norepinephrine reuptake inhibitor (SNRI); tricyclic antidepressant | Details | |
C01788 | BRD-K85402309 | dovitinib | CSF1R|EGFR|FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|INSR|KDR|KIT|PDGFRA|PDGFRB | EGFR inhibitor; FGFR inhibitor; FLT3 inhibitor; PDGFR tyrosine kinase receptor inhibitor; VEGFR inhibitor | Details | |
C01789 | BRD-A46179541 | doxapram | KCNK3|KCNK9 | potassium channel blocker | Details | |
C01790 | BRD-A13188892 | doxazosin | ADRA1A|ADRA1B|ADRA1D|KCNH2|KCNH6|KCNH7 | adrenergic receptor antagonist | Details | |
C01791 | BRD-K37694030 | doxepin | ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HRH2|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|KCNH2|SLC6A2|SLC6A4 | histamine receptor antagonist | Details | |
C01792 | BRD-K82928892 | doxercalciferol | VDR | vitamin D receptor agonist | Details | |
C01793 | BRD-K58262659 | doxifluridine | TYMS | thymidylate synthase inhibitor | Details | |
C01794 | BRD-K70507123 | doxofylline | ADORA1|PDE4A|PDE4B|PDE4C|PDE4D | adenosine receptor antagonist | Details | |
C01795 | BRD-K92093830 | doxorubicin | TOP2A | topoisomerase inhibitor | Details | |
C01796 | BRD-A08545410 | doxycycline | MMP8 | metalloproteinase inhibitor | Details | |
C01797 | BRD-M28128163 | doxycycline-hyclate | bacterial 30S ribosomal subunit inhibitor | Details | ||
C01798 | BRD-A44008656 | doxylamine | CHRM1|HRH1 | histamine receptor antagonist | Details | |
C01799 | BRD-K37087535 | DPC-681 | HIV protease inhibitor | Details | ||
C01800 | BRD-K01824921 | DPCPX | ADORA1|ADORA2A|ADORA2B|ADORA3 | adenosine receptor antagonist | Details |